PMID- 24231295
OWN - NLM
STAT- MEDLINE
DCOM- 20140929
LR  - 20131115
IS  - 1576-8260 (Electronic)
IS  - 0004-0614 (Linking)
VI  - 66
IP  - 9
DP  - 2013 Nov
TI  - Perioperative complications and surgical oncology outcomes in an initial study 
      from 84 patients submitted to laparoscopic radical cystectomy.
PG  - 851-8
AB  - OBJECTIVES: The Gold Standard treatment for a non-metastatic, invasive bladder 
      cancer is an open radical cystoprostatectomy (ORCP). Laparoscopic radical 
      cystoprostatectomy (LRCP) is still an experimental technique in evaluation. We 
      describe our perioperative results defined as surgical and safety oncology 
      variables. METHODS: Every patient who underwent a LRCP between January 2007 and 
      July 2011 in the urology department of the University Public Hospital was 
      evaluated. We perform a descriptive retrospective analysis. RESULTS: We evaluated 
      84 patients, 72 males and 12 females, with a mean age of 68 (44-79). A Bricker 
      diversion was performed in 80 patients, a Camey II bladder replacement was 
      performed in 3 patients, and a Studer bladder replacement was performed in 1 
      patient. Seventeen patients (20.23%) presented with previous abdominal surgery, 
      and 6 patients (7.14%) presented a medical history of urological surgery. The 
      mean surgery time was 257.57 minutes (180-420). The mean hospital stay was 11.875 
      days (standard deviation (SD): 6.28). The onset of tolerance to surgery occurred 
      after 3.7 days (SD: 2.21).The transfusion rate after surgical intervention was 
      20.2%. The mean number of nodes removed, by means of ilio-obturator 
      lymphadenectomy, was 17 (13-19). There were no intraoperative complications. 
      Early complications (less than 1 month after the intervention) occurred in 28 
      patients (33.3% ).There were no post-operative deaths. There were late 
      complications (starting one month after the intervention) in 7 patients (8.3% ). 
      CONCLUSIONS: Our study demonstrated that LRCP is safe and reproducible and 
      represents a minimally invasive option for patients with infiltrative bladder 
      cancer.
FAU - Ortiz-Sanchez, Lorena
AU  - Ortiz-Sanchez L
AD  - Urology Service.Hospital Universitario de Leon. Leon.Spain.
FAU - Campanario-Perez, Francisco
AU  - Campanario-Perez F
FAU - Garcia-Diez, Fructuoso
AU  - Garcia-Diez F
FAU - Beneitez-Alvarez, Manuel Emilio
AU  - Beneitez-Alvarez ME
FAU - Alonso-Prieto, Miguel Angel
AU  - Alonso-Prieto MA
FAU - Guerreiro-Gonzalez, Rafael
AU  - Guerreiro-Gonzalez R
FAU - Rado-Velazquez, Miguel Angel
AU  - Rado-Velazquez MA
FAU - Roa-Luzuriaga, Juan Manuel
AU  - Roa-Luzuriaga JM
FAU - Viggiano-Romano, Angello Maria
AU  - Viggiano-Romano AM
FAU - De Arriba-Alonso, Mario
AU  - De Arriba-Alonso M
FAU - Sanz-Ruiz, Alejandro
AU  - Sanz-Ruiz A
FAU - Flores-Carvajal, Javier
AU  - Flores-Carvajal J
FAU - Gallo Rolania, Francisco Javier
AU  - Gallo Rolania FJ
LA  - eng
LA  - spa
PT  - Journal Article
PL  - Spain
TA  - Arch Esp Urol
JT  - Archivos espanoles de urologia
JID - 0064757
SB  - IM
MH  - Adult
MH  - Aged
MH  - Antibiotic Prophylaxis
MH  - Cystectomy/adverse effects/*methods
MH  - Female
MH  - Humans
MH  - Intestines/transplantation
MH  - Intraoperative Complications/*epidemiology/therapy
MH  - Laparoscopy/adverse effects/*methods
MH  - Longevity
MH  - Male
MH  - Middle Aged
MH  - Postoperative Care
MH  - Postoperative Complications/*epidemiology/therapy
MH  - Risk Assessment
MH  - Treatment Outcome
MH  - Ureter/surgery
MH  - Urinary Bladder Neoplasms/*surgery
EDAT- 2013/11/16 06:00
MHDA- 2014/09/30 06:00
CRDT- 2013/11/16 06:00
PHST- 2013/11/16 06:00 [entrez]
PHST- 2013/11/16 06:00 [pubmed]
PHST- 2014/09/30 06:00 [medline]
PST - ppublish
SO  - Arch Esp Urol. 2013 Nov;66(9):851-8.